These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38456273)

  • 1. Genetic Testing Yield and Clinical Characteristics of Hypertrophic Cardiomyopathy in Understudied Ethnic Groups: Insights From a New Zealand National Registry.
    Earle NJ; Winbo A; Crawford J; Wheeler M; Stiles R; Donoghue T; Stiles MK; Hayes I; Marcondes L; Martin A; Skinner JR
    Circ Heart Fail; 2024 Mar; 17(3):e010970. PubMed ID: 38456273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic testing in Polynesian long QT syndrome probands reveals a lower diagnostic yield and an increased prevalence of rare variants.
    Winbo A; Earle N; Marcondes L; Crawford J; Prosser DO; Love DR; Merriman TR; Cadzow M; Stiles R; Donoghue T; Stiles MK; Hayes I; Skinner JR
    Heart Rhythm; 2020 Aug; 17(8):1304-1311. PubMed ID: 32229296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Profile and Health Disparities in a Multiethnic Cohort of Patients With Hypertrophic Cardiomyopathy.
    Butters A; Semsarian CR; Bagnall RD; Yeates L; Stafford F; Burns C; Semsarian C; Ingles J
    Circ Heart Fail; 2021 Mar; 14(3):e007537. PubMed ID: 33724884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic characterization and genotype-phenotype associations in a large cohort of patients with hypertrophic cardiomyopathy - An ancillary study of the Portuguese registry of hypertrophic cardiomyopathy.
    Lopes LR; Brito D; Belo A; Cardim N;
    Int J Cardiol; 2019 Mar; 278():173-179. PubMed ID: 30554928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethnicity Is Associated With Differing Presentation and Outcomes of Patients Undergoing Aortic Valve Replacement for Calcific Aortic Stenosis in Aotearoa New Zealand.
    Sugunesegran R; Harrison S; Parry D; Sneddon K; de Lange M; Galvin S; Stewart R; Wong B; Whalley G; Davis P; Coffey S
    Heart Lung Circ; 2023 Dec; 32(12):1512-1519. PubMed ID: 38030471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical exome sequencing unravels the diverse spectrum of genetic heterogeneity and genotype-phenotype correlations in hypertrophic cardiomyopathy.
    Harikrishnan S; Koshy L; Ganapathi S; Jeemon P; Ramya Das NK; Urulangodi M; Madhuma M; Vysakh Y; Subran A; Lakshmikanth LR
    Int J Cardiol; 2024 Sep; 411():132273. PubMed ID: 38880420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Gene Variants in Hypertrophic Cardiomyopathy in the Era of Next-Generation Sequencing.
    Burns C; Bagnall RD; Lam L; Semsarian C; Ingles J
    Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28790153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Population-Based Registry of Patients With Inherited Cardiac Conditions and Resuscitated Cardiac Arrest.
    Rucinski C; Winbo A; Marcondes L; Earle N; Stiles M; Stiles R; Hooks D; Neas K; Hayes I; Crawford J; Martin A; Skinner JR
    J Am Coll Cardiol; 2020 Jun; 75(21):2698-2707. PubMed ID: 32466885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethnic disparities in the incidence and outcome from out-of-hospital cardiac arrest: A New Zealand observational study.
    Dicker B; Todd VF; Tunnage B; Swain A; Conaglen K; Smith T; Brett M; Laufale C; Howie G
    Resuscitation; 2019 Dec; 145():56-62. PubMed ID: 31585186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic spectrum of the first Belgian
    Boen HM; Alaerts M; Van Laer L; Saenen JB; Goovaerts I; Bastianen J; Koopman P; Vanduynhoven P; De Vuyst E; Rosseel M; Heidbuchel H; Van Craenenbroeck EM; Loeys B
    Front Genet; 2024; 15():1392527. PubMed ID: 38836037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment.
    Das K J; Ingles J; Bagnall RD; Semsarian C
    Genet Med; 2014 Apr; 16(4):286-93. PubMed ID: 24113344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
    Bonaventura J; Rowin EJ; Chan RH; Chin MT; Puchnerova V; Polakova E; Macek M; Votypka P; Batorsky R; Perera G; Koethe B; Veselka J; Maron BJ; Maron MS
    J Am Heart Assoc; 2024 May; 13(10):e033565. PubMed ID: 38757491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients.
    Hathaway J; Heliö K; Saarinen I; Tallila J; Seppälä EH; Tuupanen S; Turpeinen H; Kangas-Kontio T; Schleit J; Tommiska J; Kytölä V; Valori M; Muona M; Sistonen J; Gentile M; Salmenperä P; Myllykangas S; Paananen J; Alastalo TP; Heliö T; Koskenvuo J
    BMC Cardiovasc Disord; 2021 Mar; 21(1):126. PubMed ID: 33673806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of genetics for risk stratification in pediatric hypertrophic cardiomyopathy.
    Mathew J; Zahavich L; Lafreniere-Roula M; Wilson J; George K; Benson L; Bowdin S; Mital S
    Clin Genet; 2018 Feb; 93(2):310-319. PubMed ID: 29053178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications.
    Ingles J; Burns C; Bagnall RD; Lam L; Yeates L; Sarina T; Puranik R; Briffa T; Atherton JJ; Driscoll T; Semsarian C
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28408708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
    Lee SP; Ashley EA; Homburger J; Caleshu C; Green EM; Jacoby D; Colan SD; Arteaga-Fernández E; Day SM; Girolami F; Olivotto I; Michels M; Ho CY; Perez MV;
    Circ Heart Fail; 2018 Sep; 11(9):e005191. PubMed ID: 30354366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation.
    van Velzen HG; Schinkel AFL; Oldenburg RA; van Slegtenhorst MA; Frohn-Mulder IME; van der Velden J; Michels M
    Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28794111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac myosin binding protein-C variants in paediatric-onset hypertrophic cardiomyopathy: natural history and clinical outcomes.
    Field E; Norrish G; Acquaah V; Dady K; Cicerchia MN; Ochoa JP; Syrris P; McLeod K; McGowan R; Fell H; Lopes LR; Cervi E; Kaski JPP
    J Med Genet; 2022 Aug; 59(8):768-775. PubMed ID: 34400558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-ethnic breast cancer case-control study in New Zealand: evidence of differential risk patterns.
    Jeffreys M; McKenzie F; Firestone R; Gray M; Cheng S; Moala A; Pearce N; Ellison-Loschmann L
    Cancer Causes Control; 2013 Jan; 24(1):135-52. PubMed ID: 23179663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
    Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
    Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.